Cite
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
MLA
Hogan II, Reed B., et al. “Dual-Histamine Receptor Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients.” Pulmonary Pharmacology & Therapeutics, vol. 63, Aug. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.pupt.2020.101942.
APA
Hogan II, R. B., Hogan III, R. B., Cannon, T., Rappai, M., Studdard, J., Paul, D., & Dooley, T. P. (2020). Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients. Pulmonary Pharmacology & Therapeutics, 63, N.PAG. https://doi.org/10.1016/j.pupt.2020.101942
Chicago
Hogan II, Reed B., Reed B. Hogan III, Tim Cannon, Maria Rappai, John Studdard, Doug Paul, and Thomas P. Dooley. 2020. “Dual-Histamine Receptor Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients.” Pulmonary Pharmacology & Therapeutics 63 (August): N.PAG. doi:10.1016/j.pupt.2020.101942.